ISN iNET-CKD Webinar: CKD associated anemia: time to question our assumptions
Anemia is a common complication of CKD and an important determinant of symptoms that impact quality of life. Despite evidence that hemoglobin varies substantially in the general population, current treatment guidelines recommend a single therapeutic range for hemoglobin in all patients with anemia and CKD. In this webinar we will review the published evidence that informed previous guidelines, present new evidence of the extent of international variation in hemoglobin from the ISN iNET-CKD cohorts and consider the case for re-evaluating previous assumptions about the nature and treatment of anemia associated with CKD.
- Review published literature on the treatment of anemia associated with CKD
- Understand international variation in the severity of and risk factors for anemia associated with CKD
- Discuss remaining uncertainties regarding CKD associated anemia and priorities for future research
Dr. Pecoits-Filho is a Senior Research Scientist at Arbor Research Collaborative for Health in Michigan, USA and a Professor of Medicine, Pontifical Catholic University of Paraná in Curitiba, Brazil. He is the current (2021-23) Chair of the Education Committee of the International Society of Nephrology. As a clinician, he has broad activities in Internal Medicine and Nephrology based at the University affiliated hospitals, where he was the Chief of the Department of Internal Medicine between 2010 and 2016, the Director of the Residency program in Nephrology from 2013 to 2016. Dr. Pecoits-Filho is the Principal Investigator for the study CKDOPPS, a multinational study on practice patterns and outcomes in chronic kidney disease and act as a Scientific Leader for clinical trials in the Americas with George Clinical. Dr. Pecoits-Filho received his MD and trained in Internal Medicine and Nephrology in Curitiba, Brazil before completing a nephrology research fellowship at the University of Missouri, Columbia and a PhD from the University of Sao Paulo. He was a visiting scholar for extended periods at the Karolinska Institute (Sweden) and the George Institute (Australia), and has participated as a principal investigator, regional leader and in steering committees in multinational clinical trials. Dr. Pecoits-Filho served as a member of the Executive Committee of the International Society of Nephrology (ISN) (2017-2019), the SONG Initiative (2017-present) and KDIGO (2016-2018).